Jump to content

Recommended Posts

Posted

http://www.medicalnewstoday.com/medical ... wsid=25244

PET/CT can identify new cancer lesions at early stage, allowing for prompt treatment

28 May 2005

A team of researchers at Johns Hopkins Medical Institutions in Baltimore, Md., reports that whole-body positron emission tomography/computed tomography (PET/CT) scans may help physicians identify new, unexpected malignant cancerous tumors in patients, according to an article in the May issue of the Society of Nuclear Medicine's Journal of Nuclear Medicine.

"PET/CT can help find additional lesions in patients known to have cancer," said SNM member Richard L. Wahl, M.D., director of nuclear medicine/PET at the Russell H. Morgan Department of Radiology and Radiological Science. PET/CT scans from nearly 2,000 cancer patients over a two-year period were evaluated retrospectively, explained Wahl, who was one of the first in the world and the first in this country to prove that PET could accurately diagnose breast cancer, melanoma and ovarian cancer and that it was superior to CT in staging lung cancer.

Wahl explained that in patients with known cancer, work-ups focus on a patient's primary disease and incidental coexistence of another primary malignant lesion can be missed. "Such newly identified lesions are often of early stage and have a better likelihood of being cured if treated promptly and aggressively," indicated Wahl, the senior author who co-wrote the JNM article, "Detection of Unexpected Additional Primary Malignancies With PET/CT,â€

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...

Important Information

By using this site, you agree to our Terms of Use.